LAVA Therapeutics NV: auditor change — LAVA Therapeutics appoints KPMG as new auditor, dismisses PwC

LAVA Therapeutics NV

Board approved KPMG as independent auditor for FY2025, dismissing PwC effective May 20, 2025.
PwC's reports for FY2023 and FY2024 were unqualified, with no adverse opinions or modifications.
No accounting disagreements with PwC; prior material weaknesses in IT controls and segregation of duties were remediated as of Dec 31, 2024.
PwC's letter agreeing with the statements is filed as Exhibit 16.1.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.99

LAVA Therapeutics NV engaged KPMG LLP as its auditor.

Action: engagement
Auditor: KPMG LLP

Exact text from the filing

On May 20, 2025, the board of directors (the "Board") of LAVA Therapeutics N.V. (the "Company"), upon the recommendation of the audit committee of the Board (the "Audit Committee"), approved the appointment of KPMG LLP ("KPMG") as the Company's independent registered public accounting firm to audit the Company's U.S. GAAP consolidated financial statements for the fiscal year ending December 31, 2025, and dismissed PricewaterhouseCoopers Accountants N.V. ("PwC").

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.99

LAVA Therapeutics NV dismissed PricewaterhouseCoopers Accountants N.V. as its auditor.

Action: dismissal
Auditor: PricewaterhouseCoopers Accountants N.V.
Successor: KPMG LLP

Exact text from the filing

On May 20, 2025, the board of directors (the "Board") of LAVA Therapeutics N.V. (the "Company"), upon the recommendation of the audit committee of the Board (the "Audit Committee"), approved the appointment of KPMG LLP ("KPMG") as the Company's independent registered public accounting firm to audit the Company's U.S. GAAP consolidated financial statements for the fiscal year ending December 31, 2025, and dismissed PricewaterhouseCoopers Accountants N.V. ("PwC").

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001104659-25-052460

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.